“Your brain thrives on connection; meeting people, interacting and sharing ideas is vital for not only your individual brain health but also our species survival” In this inspiring conversation, and as part of touchNEUROLOGY’s Future Leaders 2025 series, we speak with Dr Hannah Critchlow, a neuroscientist, bestselling author, broadcaster, and Science Outreach Fellow at Magdalene […]

What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.

“I have learned to value meeting patients where they are, listening with empathy, and offering structure, which can build trust, strengthen compliance, and improve outcomes.”   Dr Anna Maria Laure, postgraduate trainee in psychiatry and psychotherapy at the Medical University of Vienna, Department of General Psychiatry and Psychotherapy, Austria, is a rising voice in European psychiatry […]

“it is great to find out that some reasoning and a prescription has helped someone turn their life around”   Dr Alexander Lisinski, resident psychiatrist at Sahlgrenska University Hospital and researcher at the Department of Pharmacology, Sahlgrenska Academy, Gothenburg, Sweden, is an emerging leader in psychiatry. His work combines rigorous clinical training with a research-driven […]

Broadest approval to date in generalized myasthenia gravis The FDA approval of nipocalimab for generalized myasthenia gravis (gMG) introduces a targeted therapy within a validated class, offering the potential for durable disease control across the broadest patient population to date. This approval represents a significant advance in a disease area long managed with broad-spectrum immunosuppressants.¹ […]

The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test, the first diagnostic blood test designed to aid in the evaluation of Alzheimer’s disease (AD), has been cleared by the US Food and Drug Administration (FDA). The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test (Fujirebio Diagnostics, Inc., Malvern, PA, USA) represents a major advancement in AD diagnostics, […]

 “this is a field where rigorous science can rapidly change lives”   Dr Bardia Nourbakhsh, Associate Professor of Neurology, Johns Hopkins University, Baltimore, MD, USA, is a rising star whose work bridges rigorous clinical neurological research with compassionate, patient-centred care. From his early fascination with the brain’s complexity to his current research into treatments for […]

Multiple sclerosis (MS) is a chronic neurological condition that often presents with vague or intermittent symptoms, making early recognition particularly challenging in primary care. As diagnostic delays can significantly impact long-term outcomes, timely identification and referral are critical. In alignment with the mission of the National Multiple Sclerosis Society (NMSS) and in recognition of #WorldMSDay, […]